Curiosis Inc. is dedicated to developing, producing, and supplying innovative systems for cell-based analysis and lab automation. Our advanced solutions are designed to enhance the efficiency, precision, and scalability of cell-based research, helping scientists and medical professionals achieve better outcomes. We strive to establish ourselves as a leader in the bioindustry, focusing on delivering products that meet the evolving needs of both scientific and medical communities. By integrating cutting-edge technologies and fostering continuous innovation, we aim to make significant contributions to the advancement of biomedical research and the improvement of global healthcare outcomes.
CUITISAN
Optimum materials were used in development of the world’s first four-sided airtight metal container – CROMOSTEEL kitchenware. CUITISAN continues to grow in line with social awareness of wellbeing and environmental pollutants emitted from kitchenware.CUITISAN never compromises in the safety of the raw materials we use, and insists on direct manufacturing by independent factories as we continue investing in the uniqueness of our products through R&D.From innovative airtight metal containers that keep food fresh for a long time to enabling the use in freezer, oven, dishwasher and microwave, CUITISAN continues to create new paradigms for the kitchen.
CUBIXEL CO., LTD.
CUBIXEL is a global optical high-tech company that acquires, processes, analyzes, and converts everything in the real 3D world into digital formats. CUBIXEL’s unique 3D hologram technologies can be applied to next-generation mobility and the metaverse.
CTCBIO INC.
CTCBIO has continued its growth through the philosophy of CTC (Change, Try, Challenge). Our businesses are composed of human drugs, animal health and health functional foods. Each system is being operated systematically and efficiently. CTCBIO possesses various core technologies including the microorganism fermentation technology, drug coating technology and DDS (Drug Delivery System), and our company is actively developing products by applying these technologies. Especially, CTCZYME developed through its independent technology was selected as the Global No. 1 Product and won the Jang Young Sil Award, and the Company is continuing to develop and release drugs that are enhanced in convenience and efficiency compared to existing drugs to be acknowledged of the technology domestically and internationally. In addition, CTCBIO has partnership agreement with multi-national groups to continue the journey on becoming a global biotechnology leader by not only expanding the businesses, but also through technology development such as the diagnosis kit, etc.
CTCELLS
CTCELLS is an innovative cancer diagnostics and drug development company founded on the belief that effective cancer care requires solutions tailored to each individual. Powered by Circulating Tumor Cell (CTC) liquid biopsy, CTCELLS enables automated isolation of diverse CTC subtypes to better capture the full biological heterogeneity of cancer. To translate these insights into actionable research and clinical value, CTCELLS integrates its proprietary Continuous Centrifugal Microfluidics (CCM) technology for robust, automated CTC processing, lossless cell staining enabled by hydrogel-based HypICC to preserve cellular information for downstream analysis, and single-cell picking to support precise molecular profiling and functional characterization. By connecting cancer-specific cellular characteristics with the most suitable therapies, CTCELLS is committed to improving patient outcomes and accelerating the development of next-generation treatments, bringing new hope to patients facing difficult-to-treat cancers. | CTCELLS is an innovative biotechnology company striving for a total solution for cancer. With platform technologies in both therapeutics and diagnostics, the RACE platform is designed to deliver safer and more effective immunotherapies by optimizing the selection and administration of treatment based on a patient’s unique immunological profile. The TRACE Platform, on the other hand, is a cutting-edge liquid biopsy system that captures all types of Circulating Tumor Cells (CTCs). This allows for more precise diagnostics and treatment planning, targeting a range of cancer types. CTCELLS is committed to improving patient outcomes by integrating the latest in scientific research and technology into their products.
CT5 Inc
CT5 Inc is a Korea-based AI wearable and mobile peripheral company. Our flagship ZONE HSS1, winner of the CES 2026 Best of Innovation in AI, is a screenless neckband with hybrid open-ear/in-ear earbuds that delivers hands-free multimodal translation, guidance and reporting for field operations.